Medical Student Places
Debate between Baroness Merron and Lord Evans of Rainow
Baroness Merron
To ask His Majesty’s Government what progress has been made on plans to increase the number of medical student places in England.
Lord Evans of Rainow (Con)
My Lords, we are on track to meet the NHS Long Term Workforce Plan and aim to double the number of medical school places in England from 7,500 to 15,000 places a year by 2031-32. We have allocated 205 additional medical school places and provisionally allocated 350 more for the 2024-25 and 2025-26 academic years respectively. In 2020, the Government completed an expansion in the number of medical school places in England from 7,500 per year, a 25% increase.
Baroness Merron (Lab)
My Lords, may I start by saying on behalf of these Benches that we wish to express our deep condolences on the sad passing of Baroness Gardner of Parkes and our colleague Baroness Massey? May their memories be for a blessing.
Ministers recently advised the Office for Students that only 350 additional places for trainee doctors would be funded in 2025-26. On the basis that, at this rate, it will take over 21 years to meet the Government’s promise to double the number of medical training places, what assessment has been made of the effect this will have on medical schools, which had in fact been told to plan for considerably greater numbers? Where does this leave the Government’s promise to double medical places by 2031?
Lord Evans of Rainow (Con)
My Lords, I would like to follow the noble Baroness’s tribute to Baroness Gardner of Parkes and Baroness Massey. I also pay tribute to the late Doug Hoyle, an outstanding north-west MP and an outstanding public servant.
We remain committed to the long-term workforce plan’s target to double the number of medical school places by 2031 and are in fact ahead of schedule. The planned expansion is not uniform in each year; it increases substantially in later years. The timeline allows for new and existing medical schools to build the physical and teaching capacity needed, and to develop curricula and receive General Medical Council approvals where needed.
Human Medicines (Amendments Relating to Coronavirus and Influenza) (England and Wales and Scotland) Regulations 2024
Debate between Baroness Merron and Lord Evans of Rainow
Baroness Merron (Lab)
My Lords, our health and care staff, scientists and others in public services, and those who volunteered, did so much to keep the public safe and to vaccinate millions across the country as quickly as possible to save lives and drive down cases of Covid-19. They finally allowed us to end lockdowns and reclaim our lives, and I pay tribute to them all.
I thank the Minister for setting out today the provisions of these regulations, which are to update legislation pertaining to the movement and supply of Covid-19 and influenza vaccines. The changes, as he said, seek to extend the sunset clauses of Regulations 3A and 19 to 1 April 2026 and to alter Regulation 247A to extend its provision, also until 2026, instead of the current restriction on its use to being only during a pandemic. Extending these provisions, which will also allow the NHS to continue to use an expanded workforce, is important to continuing to allow the deployment of safe and effective Covid-19 and influenza vaccines at the pace and scale required to keep us all protected. The draft regulations aim to build on the work of the Covid-19 vaccine rollout across the country, and we certainly support them.
As the Minister said, the consultation last year confirmed that the provisions have found considerable favour with stakeholders in the health and care sector. Regulation 247A appears to have reduced workforce pressures while increasing flexibility in the workforce and providing opportunities for career progression. On all fronts, that has to be a good thing.
I note that the impact assessment highlights the positive expected value of these regulations and concludes that vaccinations are a powerful and beneficial tool in tackling viruses and diseases such as influenza and Covid-19. The impact assessment also refers to the work to move towards a permanent approach, which will likely alter these provisions again in the future. Can the Minister provide noble Lords with more detail about the progress the department has made in its planning for a more permanent approach?
The important matters of vaccine take-up, hesitancy and misinformation have of course come to the fore of late, given the recent measles outbreak across the country. All these matters have impacted in that too few have been protected against a potentially deadly virus. I recently asked the noble Lord, Lord Markham, as the Minister in the Chamber, about using pharmacists to vaccinate against measles through the delivery of the MMR vaccine, which he welcomed. I wonder whether the Minister today could undertake today to let me know what response the department gave to my suggestion. I appreciate that I had directed that question to the noble Lord, Lord Markham, but I am sure that the Minister will be able to assist, even if it is after this debate.
The Government have been called on to extend this winter’s Covid vaccination booster programme to 12 million people in the 50 to 64 age cohort. Can the Minister explain why the provision was not extended to that age cohort? What is the assessment of the impact of this on the health of both that group and those beyond it? Can the Minister share any details about whether and when Covid-19 vaccinations will be available privately?
Last winter, influenza admission rates were 2.6 times higher for those who live in the most deprived areas than for those who live in the least deprived areas, while Covid-19 admission rates were 2.1 times higher. The rate of emergency hospital admissions for influenza was 1.6 times higher for black British people and other minority ethnic groups than for white ethnic groups. What are the Government doing to address these inequalities?
Finally, can the Minister confirm what the Government are doing to tackle the vaccine misinformation that continues to be shared so widely across the country? As I said, we support this draft statutory instrument so that we can ensure the supply, and improve the take-up of, safe and effective Covid-19 and influenza vaccines at the pace and scale required.
Lord Evans of Rainow (Con)
My Lords, I am most grateful to noble Lords; in closing, I thank all noble Lords for participating in this debate. We always have healthy questions and, I hope, answers in this Room.
Extending these provisions will ensure that the important flexibilities established by these regulations are maintained, thereby supporting the continued safe and effective deployment of Covid-19 and flu vaccines to the pace and scale required. The Government will continue to work with system partners to consider fully a long-term mechanism to support the delivery and administration of Covid-19 and flu vaccines. This process is already under way; any new measures will of course be subject to public consultation. However, in the immediate term, given the high level of support expressed in the consultation, there is an ongoing need to support the continued safe and effective supply, distribution and administration of Covid-19 and flu vaccines by maintaining the existing provisions provided by these regulations to April 2026.
Let me answer to the specific questions that I was asked by the noble Lord, Lord Allan of Hallam and the noble Baroness, Lady Merron. They asked what the longer-term plans are for these regulations. It is important that we retain current flexibilities to continue to protect those at greatest risk, but we agree on the importance of long-term solutions, working with the system partners to undertake a fuller consideration of long-term plans. We do not want to pre-empt that process but can confirm that we will be informed by a full consultation, including in the House. We will certainly have opportunities to discuss this issue at length.
The noble Lord, Lord Allan, talked about his experience during Covid, as I presume most of us in this place experienced. He mentioned that he had injections from a solider, a nurse and another person, indicating that he had three injections. I remember, from my experience before I came to this place, how successful it was. It was a very British experience: it was in a community hall, with which we are all familiar, and a car park. We all queued in the rain, very British-like, ready to go in. We were met and greeted by volunteers; that was the first thing I noticed. The local CCG banners were around; it was very orderly and very dignified—very British. From what I remember, there was no soldier; they were NHS personnel, clearly identified, and we were all sifted through. The lessons that I took from it were that it is local but also national, and it is about volunteering as well. We have to work together on this, with government, local NHS provision and good vaccine provision working together, but you are reliant on volunteers to do it. In my experience, it worked very well.
As for who can deliver the vaccines and the flexibilities, as I indicated, in my experience and that of the noble Lord, it is healthcare professionals who deliver them. We discussed this yesterday in the Chamber, and the noble Baroness mentioned pharmacists. It is clear that other qualified and well-trained individuals, under supervision from healthcare professionals, can and should be able to do this. The lesson learned is that you can extend the number of individuals under supervision —who are very well trained—to make sure that there are no bottlenecks and you can open it up. That is the big lesson we can take from Covid.
This was introduced after the initial planning and preparation for a flu pandemic in 2016 so, on the noble Lord’s point about preferring to have pre-planned systems—the known unknowns, as he said—we have to be mindful of the unknown unknowns. We planned for influenza, not Covid-19. We in this House and elsewhere try our best to plan for the future but it is difficult. However, we can certainly learn from that and, as the noble Lord said, this has been well documented for the Government and the nation. So we have to learn the lessons from the planning for influenza from 2016 to 2019—only three years. God forbid that we have another pandemic, but we hope we will know about that. It is about making provision so that we can extend the workforce to deliver those vaccines.
On the specific question that the noble Baroness asked my noble friend Lord Markham, I will endeavour to get a specific answer if she has not already received one. She talked specifically about MMR, which we discussed previously. Some communities are perhaps vaccine-reluctant, for whatever reason. We mentioned that, in the black and ethnic minority communities, social deprivation has a lot to do with it in certain areas of the country—inner cities—as does misinformation.
Both the noble Lord, Lord Allan of Hallam, and the noble Baroness, Lady Merron, mentioned disinformation, which we have talked about before. Social media has a positive effect on our lives but, unfortunately, it is very easy to develop conspiracy theories from it. The Government are committed to tackling Covid-19 vaccine misinformation. At a national level, the Government, NHS England and UKHSA work together to create a range of personalised and accessible communications from trusted sources to maximise awareness, understanding and confidence in vaccines. At a local level, the NHS works with community leaders to design bespoke materials and services suited to their local populations, which may include outreach initiatives aimed at improving confidence and trust in the vaccines.
The conspiracy theories come from all sorts of places. The vaccines are perfectly safe. There may be occasions when individuals have allergic reactions to them, but this does not mean that people should not be vaccinated or that your children should not be vaccinated for MMR. I am afraid that one of the battles of the 21st century is trying to make sure that that disinformation does not have a detrimental effect on our children.
On what the Government have been doing, over 149 million Covid-19 vaccination doses were administered in England between December 2020 and 2023. This has saved tens of thousands of lives, significantly reducing the pressure on the NHS and allowing the economy and society to reopen. Since 11 September, when the latest autumn booster programme commenced, more than 11.8 million Covid-19 jabs have been delivered, providing vital protection to those at greater risk of severe illness.
To summarise, I believe that the long-term plan is to give that flexibility proactively. We cannot predict the future, but we can certainly learn from Covid-19, from 2020 to 2022, that the ability to expand a vaccine and its administration is critical, getting it in the right place at the right time. On the question asked by the noble Baroness, Lady Merron, about hard-to-reach communities, it is about communication and going through community leaders, but it is also about having the wherewithal so that people are not suspicious of going to a local community hall, where they will be welcomed by volunteers perhaps and injected by the appropriate people. We hope that can wear down this reluctance to take up life-saving vaccines.
Lung Cancer Medicines
Debate between Baroness Merron and Lord Evans of Rainow(2 months, 2 weeks ago)
Lords ChamberRead Full debate Read Hansard Text
Lord Evans of Rainow (Con)
The noble Lord raises a good point, and I agree with it. Since 2016, the cancer drugs fund, worth £340 million per year, has delivered faster access for tens of thousands of NHS patients to some of the most promising new cancer medicines—in some cases, up to eight months faster, including for Pembrolizumab and Selpercatinib. These are two very important drugs, and the hope is that they will be successful moving forward. Only time will tell, but the Government are committed to introducing life-saving drugs.
Baroness Merron (Lab)
The Pharmaceutical Journal found last year that inequity of access through the compassionate use programme has become a significant issue, with some trusts not using the programme at all. What steps are the Government taking to ensure that new and existing patients across the country will be able to access Mobocertinib and other treatments for lung cancer?
Lord Evans of Rainow (Con)
I thank the noble Baroness for that question. As I have outlined in my previous answers, to the best of my knowledge, the existing drug will be allowed but some of the newer ones will be introduced and available. If the noble Baroness knows of specific trusts that do not make this available, I ask her to please let me know and I will look into it.
Child Obesity
Debate between Baroness Merron and Lord Evans of Rainow
Lord Evans of Rainow (Con)
I am not aware that I am painting a rosy picture. There are serious issues with childhood obesity in this country, as there are in other countries around the world. Nearly one in 10 children, 9.2%, start primary school living with obesity, and approximately one in five children, 22%, leave primary school living with obesity. Children living in the most deprived areas are more than twice as likely to be living with obesity as those living in the least deprived areas. Obesity costs the country an estimated £58 billion. The Government are doing all we can to help reduce that from an early age.
Baroness Merron (Lab)
My Lords, given the Minister’s response just now, does he acknowledge that the Government’s childhood obesity plan has presented us with what NHS England now describes as “a ticking health timebomb”? What assessment have the Government made of the impact of their own flagship sugar reduction programme managing only a 3.5% reduction and failing to meet its 20% target?
Lord Evans of Rainow (Con)
I am grateful to the noble Baroness, who raises a very important subject. It is not unique to the United Kingdom: many countries in the western world have this issue with childhood obesity. Sugar intakes in children aged one to 18 in the UK are double the recommended maximum level and more than 5% of daily energy intake. Consuming too much sugar can lead to weight gain, which in turn increases the risk of serious diseases, such as cancer, heart disease, type 2 diabetes and Covid-19. It also increases the risk of tooth decay. Modelling shows that children who are overweight or living with obesity consume between 140 and 500 excess calories a day, depending on the age and gender. The Government are working hard and doing a huge amount to reduce childhood obesity, but there is clearly a lot more to be done.
Measles Cases
Debate between Baroness Merron and Lord Evans of Rainow
Baroness Merron
To ask His Majesty’s Government what assessment they have made of the declaration of a national health incident by the UK Health Security Agency over a surge in measles cases across the country.
Lord Evans of Rainow (Con)
My Lords, the UK Health Security Agency declared a national incident on 8 January 2024. The government health system is taking control of the disease’s spread. Our aim is to protect as many individuals as possible through convenient vaccination, targeting our offer to low-uptake communities; to contain outbreaks by working with local partners to effectively contact, trace and reduce risk to the most vulnerable; and to promote vaccination through engagement and communication with GPs, teachers and trusted community leaders.
Baroness Merron (Lab)
My Lords, this is a grave yet preventable situation, especially as 80 countries across the world are measles-free while the UK has lost its status. I am sure that the Minister recognises that the Government should have read the warning signs and acted sooner to tackle vaccine hesitancy and low take-up. How will lessons be learned from the pandemic and used to focus on the communities, children and young people at greatest risk? Will a taskforce be established to co-ordinate relevant partners and oversee a rapid improvement to get to the WHO 95% target for take-up?
Lord Evans of Rainow (Con)
From 1 January 2023 to 30 November 2023 there were 209 laboratory-confirmed measles cases in England. Over three-quarters of those cases are from the West Midlands, predominantly Birmingham and Coventry. In the West Midlands, an NHS integrated care board system partnership group has been establishing and co-ordinating a regional response. Extensive local communications and engagement have been undertaken in the West Midlands alongside the immediate response to support the uptake of the measles, mumps and rubella vaccine. Nationally, the UK Health Security Agency has established an incident management team to oversee the public health response to the outbreak. The noble Baroness is exactly right: this country had a proud record on vaccination prior to Covid-19 but there has been a decline in recent years since the pandemic, and we have to do more to get back our status.
Deaths: Younger Age Cohorts
Debate between Baroness Merron and Lord Evans of Rainow
Lord Evans of Rainow (Con)
I pay tribute to the noble Lord’s expertise in this matter. I cannot say that I am content, but I can say that the Government have improved the NHS health check, our national cardiovascular disease prevention programme, investing almost £17 million in an innovative new digital NHS health check to be rolled out from spring 2024, which is expected to deliver an additional 1 million checks in the first four years, and investing £10 million in a pilot to deliver up to 150,000 CVD checks in workplace settings. In the olden days, when we had manufacturing factories, the workforce had nurses who used to look after their health and well-being. Sadly, that is not the case these days and the Government are trying to replicate that in the workplace. But the noble Lord raised an important point, and I will take it back to the department so that I can be reassured about what he asked.
Baroness Merron (Lab)
My Lords, the Lancet found that deaths from cardiovascular disease among those aged 50 to 64 are one-third higher than over the previous five years. To what extent do the Government assess that this comes down to the relevant average ambulance response times being consistently above 30 minutes since the beginning of 2022? For those who are suffering heart attacks or strokes, how will the fact that the Government have now increased the target for ambulance response times help to ensure that lives are being saved?
Lord Evans of Rainow (Con)
The noble Baroness is absolutely right to raise this point. I am not aware of the significance of her point on ambulance times, but the NHS makes every effort, through rigorous contingency planning, to minimise the disruption. The ambulance service does a good job, but clearly it has to do more. I will write to her on the specific point about ambulance times.
Vector-borne Diseases
Debate between Baroness Merron and Lord Evans of Rainow(4 months, 2 weeks ago)
Lords ChamberRead Full debate Read Hansard Text
Lord Evans of Rainow (Con)
The Government are doing exactly that and investing significantly into research. In terms of any private sector business that is looking into this, they should please contact me or the government department and we will work with them. If there is any research and development that we are not aware of, we are very keen to hear about it.
Baroness Merron (Lab)
My Lords, the analysis in the UKSA report referred to by the right reverend Prelate uses a high-end global warming scenario to represent a worst-case situation without mitigation and adaptation. Could the Minister advise how government planning is based on other scenarios at different rates of climate change? How are the agreements at the recent COP 28, and previously, expected to affect the conditions in which vector-borne diseases proliferate?
Lord Evans of Rainow (Con)
The short answer to that is that we cannot be sure. A noble Lord asked about London and the south-east: that is a worst-case scenario. It is predicted to increase in the second half of the 21st century. As I have said previously, we need to monitor it in 2023 and onwards. Certainly, the south of England is warmer than the north and north-west of England; we just need to monitor it. These are worst-case scenarios of these diseases coming into the country. It is right and proper that we monitor them, and that we monitor them at the ports of entry—but it is a worst-case scenario and it may or may not happen this century.
NHS: General Medical Practitioners
Debate between Baroness Merron and Lord Evans of Rainow(5 months, 1 week ago)
Lords ChamberRead Full debate Read Hansard Text Read Debate Ministerial Extracts
Lord Evans of Rainow (Con)
I am grateful to my noble friend. I am aware of the Armed Forces scheme—that if you train as a pilot, for example, you cannot leave the Royal Air Force to become an airline pilot. It is not the first time that this question has been asked, and I will feed it back to the department.
Baroness Merron (Lab)
My Lords, the Royal College of GPs reports that 40% of its members consider their premises not fit for purpose, something that is not addressed by the workforce plan. As the £10.2 billion backlog in maintenance continues to worsen as capital budgets continue to be raided for day-to-day spending, what strategy do the Government have to ensure that patients can receive care in modern, safe and properly maintained buildings, particularly where an increase in GPs and primary care staff teams is being promised?
Lord Evans of Rainow (Con)
The noble Baroness is absolutely right. GP practices’ premises vary throughout the country but, as I said earlier, there is capital funding available for new practices. From my own experience, when GP practices merge it gives an opportunity for them to have a purpose-built building. When I was a Member of Parliament there was a very good example of that where four GP practices throughout the constituency came together to form an outstanding modern GP practice with a new GP practice building.
NHS Waiting Times: Long-Term Sickness Absence
Debate between Baroness Merron and Lord Evans of Rainow
Baroness Merron
To ask His Majesty’s Government what recent assessment they have made of the impact of NHS waiting times on the number of people off work due to long-term sickness.
Lord Evans of Rainow (Con)
My Lords, I first pay tribute to the noble Baroness for her work on the Board of Deputies of British Jews at this very difficult time. We are very lucky to have her in this place.
Cutting waiting lists is one of the Government’s top priorities. We consistently assess the size of waiting lists and progress in reducing long waits. We are delivering our elective recovery plan and have virtually eliminated two-year and 18-month waits. The most clinically urgent patients continue to be treated first. We are working with the Department for Work and Pensions to understand and explore solutions to the impact of elective waits on economic inactivity.
Baroness Merron (Lab)
Before responding on the Question, I thank the Minister for his kindness, his generous comment and his support for the Jewish community and others at this time.
An all-time high of more than 2.6 million people do not have jobs because of ill health, including long Covid, while the CQC has found that two in five people admitted to hospital for planned care had their health worsen while they were on the waiting list. So does the Minister accept that ever-lengthening waiting lists and difficulties in accessing treatment are affecting people’s livelihoods as well as the economy? How do the Government plan to address this?
Blood Donation
Debate between Baroness Merron and Lord Evans of Rainow
Lord Evans of Rainow (Con)
I am grateful to my noble friend for her question and for describing her particular circumstances; I thank her for her donations. I will take her specific case back to the department and respond in writing.
Baroness Merron (Lab)
My Lords, last October included the first ever amber alert on blood stock shortages. More than 325,000 people registered to give blood; however, only one in four of those has attended an appointment since, and only one in five has donated blood since. Have the Government investigated why the numbers registering have not translated into blood donations? What steps are being taken to ensure that people not only register but follow through to make a donation?
Lord Evans of Rainow (Con)
I am grateful to the noble Baroness, who raises a very good point. Yes, there was an amber alert in 2022, when blood stocks fell below two days. That is not the case any more; stocks are currently at the target levels of six days. As the noble Baroness said in her very good question, some people register but either do not attend or attend for the first time only. The department is looking at the reasons for that, but that is why it has a thorough marketing campaign to write to people using social media. In my own case, I remember being telephoned on several occasions to go to donate. It is not easy and straightforward; I cannot say to the noble Baroness that there is a magic wand to prevent people registering but not turning up. This is a case of constantly keeping social media and marketing campaigns going to make sure that we get new donors. We need a new generation of donors; the average donor is, like me, over 45.
Metastatic and Secondary Breast Cancer
Debate between Baroness Merron and Lord Evans of Rainow
Lord Evans of Rainow (Con)
I bow down to the noble Lord’s expertise on this. What I said is that I did not have the answer at the Dispatch Box and that I would take the question away and report back to the department so that the noble Baroness can get a fulsome answer.
Baroness Merron (Lab)
My Lords, the number of breast screenings fell below acceptable levels in the years ending March 2021 and March 2022, when uptake at first invitation fell to under 50% across England for the first time. While this might be expected given the impact of the pandemic, what assessment have the Government made of the backlog and its implications, and what remedial steps are they taking to increase screening rates and decrease the cancer risk for women?
Lord Evans of Rainow (Con)
The noble Baroness is absolutely right. The Government are increasing the available sites for screening. In terms of specific details, I will come back to her in writing. We have expanded facilities across the United Kingdom to make sure that screening sites are readily available in local communities.
Drugs: Supply and Availability
Debate between Baroness Merron and Lord Evans of Rainow
Lord Evans of Rainow (Con)
My noble friend raises a very important point. Social media has a detrimental effect on the health and well-being of young girls—celebrities latch on to these things and it goes viral. The prescribers, whether NHS or private, are accountable for their prescribing decisions. They are expected to take account of appropriate national guidance. It is for the responsible clinician to work with their patient and decide on the course of treatment, with the provision of the most clinically appropriate care for the individual always the primary consideration. We will always work with clinicians to ensure that these drugs are prescribed as safely as possible, alongside specialist weight-management services.
Baroness Merron (Lab)
My Lords, a recent survey by the Pharmaceutical Journal listed serious shortages over the last year in the availability of treatments for common conditions, including menopause symptoms, high cholesterol, high blood pressure and osteoporosis, such that pharmacists were unable to provide the necessary medication. What assessment has been made of the effect of medicine shortages on people with those conditions? Does the Minister share my concern about the associated impact of these shortages on the NHS, in pressures as well as increased costs?
Lord Evans of Rainow (Con)
I share the concerns of the noble Baroness. Medicine supply problems can occur for a number of reasons, and occasionally the NHS experiences shortages of specific medicines, which may be temporary and localised. We want to assure people that the department has well-established processes to prevent, manage and mitigate medicine shortages. The noble Baroness mentioned HRT. There are 70 hormone replacement therapy products, and the vast majority are in good supply. There have been issues with the supply of a limited numbers of HRT products, primarily due to a very sharp increase in demand, but the supply position for the majority of HRT products has improved considerably over the last year.
Health: Economic Inactivity
Debate between Baroness Merron and Lord Evans of Rainow
Lord Evans of Rainow (Con)
The noble Lord is absolutely right to talk about data and how we can learn from it. It is currently difficult to quantity the direct effects of this, but it is indeed a factor. Data on employment rates suggests that those awaiting treatment were often already inactive before Covid, and it is therefore possible that longer waiting lists may be exacerbating this. But the noble Lord raised a good point, and I agree with him: that is what the Government will be doing, because it is important to take each patient on a case-by-case basis, rather than a one-size-fits-all approach.
Baroness Merron (Lab)
My Lords, ONS data shows that, for every 13 people working, one is suffering long-term sickness—a record number of people not in work due to ill health. So could the Minister commit to expanding and tailoring specialist help for those who cannot re-enter the workplace due to long-term ill health? What preventative provision will be made to tackle the increase in mental health issues in young people and the increased incidence of back and neck pain, which are major contributors to the unprecedented numbers of people who are unable to work?
Lord Evans of Rainow (Con)
New investment in the Spring Budget broadens access to additional work-coach support for disabled people and those with health conditions, it introduces a new supported employment programme and it focuses on providing faster access to joined-up work and health support, including for mental health and musculoskeletal conditions—the two leading causes of economic inactivity due to long-term sickness. But the noble Baroness raises an important point: the Covid period exacerbated all of this, and the system is under pressure. As I said in my earlier answer, the best way to do it is to take each patient on a case-by-case basis to ensure that there is help and support into work. Jobcentre Plus is doing an amazing job on that, working with the health service.
Secondary Metastatic Breast Cancer
Debate between Baroness Merron and Lord Evans of Rainow
Lord Evans of Rainow (Con)
The department has committed an additional £8 billion from 2022-23 to 2024-25, on top of the £2 billion elective recovery fund and the £700 million targeted investment fund already made available to the NHS. The Autumn Statement 2022 provided additional funding of £3.3 billion, and £3.3 billion for 2024-25, to support the NHS in managing the pressures that it faces.
Baroness Merron (Lab)
My Lords, modelling from Cancer Research UK shows that the number of cancer cases in the UK is projected to rise by as much as a third in the next 15 years. As it takes 15 years to train an oncologist, a pathologist, a radiologist or a surgeon, can the Minister assure the House that the Government’s very long-awaited workforce plan will give transparent and ambitious projections for 10, 15 and 20 years into the future, to reflect the time it takes to train the cancer specialists that patients need?
Lord Evans of Rainow (Con)
The target within the cancer workforce plan of more than 4,000 staff members for 2016 and 2021 was exceeded by 226, with an annual growth rate of the cancer workforce of 3% to 4%. The Government have committed to publishing an NHS long-term workforce plan for the next 15 years, covering doctors, nurses and other key professionals. This should be published in spring 2023. In 2023-24, NHS England will continue to make investments in education and training to increase capacity in the cancer and diagnostics workforce, building on the £81 million invested in 2022-23.
Brain Tumours
Debate between Baroness Merron and Lord Evans of Rainow
Lord Evans of Rainow (Con)
I thank my noble friend for that question. I was indeed running the London marathon yesterday and took note of all the wonderful cancer charities, including those that my noble friend mentioned, as they were running past me—which is an indication of how slowly I was going. They were going a lot quicker than I was. However, the serious point is that the London marathon is a wonderful British institution that raises millions of pounds for charity, and an awful lot of cancer charities benefit from it.
Baroness Merron (Lab)
My Lords, I congratulate the Minister and others in this House on their efforts yesterday and pay tribute to the tireless work of the Tessa Jowell Foundation. It deserves our support for how it presses home the need for urgent improvements in treatment research and training to combat the rising devastation of brain cancer. However, while survival rates for glioblastoma are shockingly poor, and the numbers are described as an epidemic, this still is not enough for a business case to encourage companies to test new drugs. How will the Government encourage longer-term investment and action to develop new drugs, and will the Minister act to increase the numbers in clinical trials?
Lord Evans of Rainow (Con)
I thank the noble Baroness, who is right to point out that the number of people surviving brain cancer has not moved in recent years. I assure her that the Government are doing all that we can. The money is there. Working with the charitable organisations, we must attract more projects and investigations on this very complicated and difficult disease.
Medical Devices and Equipment
Debate between Baroness Merron and Lord Evans of Rainow
Lord Evans of Rainow (Con)
I thank my noble friend for his question. The Government’s medtech strategy, published in February, will support medical device manufacturers by recognising the importance of domestic production to support resilience and identify practical support. The good news that was articulated in the Budget last week can only add to that.
Baroness Merron (Lab)
My Lords, rising cost pressures affect not only the supply of medical devices and equipment; spiralling costs are also threatening the supply of drugs in the UK, particularly generic medicines. What assessment have the Government made of how many drug companies they expect to exit this market altogether due to lack of profitability? What assessment have they made of the impact on patient care and NHS finances if the NHS has to pay an increasing amount for a smaller range of drug options?
Lord Evans of Rainow (Con)
When agreeing contracts with healthcare manufacturers that stipulate fixed pricing the manufacturers have full opportunity to account for the inflationary pressures of their tenders. NHS Supply Chain has established processes, where suppliers can apply for price increases due to exceptional circumstances. It has accepted price increases where they were justifiable, and it continues to consider such requests.
HIV Transmission
Debate between Baroness Merron and Lord Evans of Rainow
Lord Evans of Rainow (Con)
I thank my noble friend for that question. We know that the HIV prevention drug PrEP is extremely effective at preventing HIV transmission. We are developing a plan to improve access to PrEP for key groups and in settings outside of sexual health services, as part of our HIV action plan commitments.
Baroness Merron (Lab)
My Lords, I too pay tribute to the late Baroness Masham; she will be much missed for her work and effectiveness not just in this area but in many others too.
Following on from the Minister’s answer to the last question, I think we all acknowledge that the great game- changer in the prevention of HIV is the cheap and simple drug PrEP. However, there is a major problem with prescription, particularly for those trying to access it for the first time. What assessment have the Government made of the incidence of HIV because people cannot easily access PrEP? Will the Minister look at extending the prescribing of HIV prevention drugs beyond hard-pressed sexual health clinics to other sources, including GPs and community pharmacies?
Lord Evans of Rainow (Con)
The noble Baroness raises a very important point. PrEP is now being commissioned as a routine service, and PrEP funding has been fully included within the public health grant, which will benefit over 80,000 people at the highest risk of HIV. But I do agree that having access through GPs would be helpful.